BioLargo, Inc.: Clyraguard Highlighted in Rolling Stone and Men's Journal

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.

Monday, 2 November 2020

Clyraguard Highlighted in Rolling Stone and Men's Journal

BioLargo and its subsidiary Clyra Medical Technologies are rolling out Clyraguard around the country, and it's starting to turn some heads. Now that the product is available on the company's website and on Amazon, the timing is perfect.

Last week, two articles were published about Clyraguard that do a great job capturing the value of this product. First, a Rolling Stone article highlighted how Clyraguard can help improve mask-wearing practices to help keep people safe. Second, a Men's Journal article reviewed the product from a broader perspective.

You can get to these articles right here:

If you are a follower of BioLargo or Clyra, we'd love to hear your thoughts about the new product. Make sure to follow us on social media - you can find us at:

Twitter: @BioLargo
Facebook: https://www.facebook.com/BioLargo1
LinkedIn: https://www.linkedin.com/company/biolargo-inc.

Monday, 2 November 2020

Clyraguard Highlighted in Rolling Stone and Men's Journal

No comments:

Post a Comment